Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

MDR-TB (multidrug-resistant tuberculosis)

  • Comparison of efficacy and safety of fixed-dose combination regimen versus separate drugs for treatment of tuberculosis
    Leila Boussoffara, Marwa Ammar, Nadia Boudawara, Soumaya Bouchareb, Imen Touil, Amani Msakni, Jalel Knani
    European Respiratory Journal Sep 2019, 54 (suppl 63) PA1062; DOI: 10.1183/13993003.congress-2019.PA1062
  • EBUS TBNA in the rapid microbiological diagnosis of drug resistant tuberculous mediastinal lymphadenopathy
    Prashant Nemichand Chhajed, Preyas J Vaidya, Neha P Mandovra, Vinod B Chavhan, Tejashree T Lele, Rekha Nair, Joerg D Leuppi, Avinandan Saha
    European Respiratory Journal Sep 2019, 54 (suppl 63) PA325; DOI: 10.1183/13993003.congress-2019.PA325
  • Impact of the introduction of a paediatric ‘virtual TB clinic’
    Louise Turnbull, Fran Child
    European Respiratory Journal Sep 2019, 54 (suppl 63) OA3823; DOI: 10.1183/13993003.congress-2019.OA3823
  • Public health guidance on programmatic management of latent tuberculosis infection in the European Union/European Economic Area
    Senia Rosales-Klintz, Marieke J. Van Der Werf
    European Respiratory Journal Sep 2019, 54 (suppl 63) OA3817; DOI: 10.1183/13993003.congress-2019.OA3817
  • Results of traditional and new regimens of MDR/XDR TB treatment: cohort analysis
    Sergey Evgenievich Borisov, Alexey Filippov, Irina Danilova, Sergey Kosenkov
    European Respiratory Journal Sep 2019, 54 (suppl 63) OA2134; DOI: 10.1183/13993003.congress-2019.OA2134
  • Drug resistance-conferring mutations in Mycobacterium-tuberculosis isolated from retreated patients in Hanoi, Vietnam
    Nguyen Thi Le Hang, Minako Hijikata, Shinji Maeda, Pham Huu Thuong, Hoang Van Huan, Nguyen Phuong Hoang, Ikumi Matsushita, Naoto Keicho
    European Respiratory Journal Sep 2019, 54 (suppl 63) OA2135; DOI: 10.1183/13993003.congress-2019.OA2135
  • Bedaquiline containing regimens for the treatment of multi- and extensively drug-resistant tuberculosis at the programmatic level in Belarus. Prospective cohort study
    Alena Skrahina, Henadz Hurevich, Sviatlana Setkina, Viatcheslav Grankov, Varvara Solodovnikova, Dzmitri Viatushka, Victoria Kralko, Dzmitry Klimuk, Masoud Dara
    European Respiratory Journal Sep 2019, 54 (suppl 63) OA2136; DOI: 10.1183/13993003.congress-2019.OA2136
  • Characteristics of drug susceptibility testing for bedaquline and clofazimine of 178 drug-resistant Mycobacterium tuberculosis isolates in Japan
    Akiko Takaki, Akio Aono, Kinuyo Chikamatsu, Yuriko Igarashi, Yoshiko Shimomura, Yoshiro Murase, Hiroko Yoshida, Yoshitaka Tamura, Takayuki Nagai, Yuta Morishige, Hiroyuki Yamada, Satoshi Mitarai
    European Respiratory Journal Sep 2019, 54 (suppl 63) OA2137; DOI: 10.1183/13993003.congress-2019.OA2137

Pages

  • Previous
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • Acute lung injury and critical care (83)
  • Asthma and allergy (666)
  • CF and non-CF bronchiectasis (278)
  • COPD and smoking (911)
  • Epidemiology, occupational and environmental lung disease (216)
  • Genetics (60)
  • Interstitial and orphan lung disease (503)
  • Lung biology and experimental studies (318)
  • Lung cancer (283)
  • Lung imaging (45)
  • Lung structure and function (303)
  • Mechanisms of lung disease (145)
  • Paediatric pulmonology (395)
  • Pulmonary pharmacology and therapeutics (141)
  • Pulmonary vascular disease (526)
  • Respiratory clinical practice (171)
  • Respiratory infections and tuberculosis (977)
  • Sleep medicine (271)

Custom Text goes here

  • Most Read
  • Twitter
Loading
  • Pulsus paradoxus
  • ERS/ATS technical standard on interpretive strategies for routine lung function tests
  • European Respiratory Society guidelines for the diagnosis of asthma in adults
  • ERS clinical practice guidelines on treatment of sarcoidosis
  • The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society